Abstract: The vascular endothelial growth factor (VEGF) family includes key mediators of vasculogenesis and angiogenesis. VEGFs are secreted by various cells of epithelial and mesenchymal origin and by some immune cells in response to physiological and pathological stimuli. In addition, immune cells express VEGF receptors and/or coreceptors and can respond to VEGFs in an autocrine or paracrine manner. This immunological role of VEGFs has opened the possibility to use the VEGF inhibitors already developed to inhibit tumor angiogenesis also in combination approaches with different immunotherapies to enhance the action of effector T lymphocytes against tumor cells. This review aims at analyzing the current knowledge on the crosstalk between VEGFs and the immune system and at highlighting those aspects that still need to be further investigated.